OVERVIEW

Acute Bronchiolitis: Assessment and Management in the Emergency Department (Pharmacology CME) is organized by EB Medicine.

Publication Date: Oct 02, 2019
CME Expiration Date: Nov 01, 2022

Accreditation:
• 4 AMA PRA Category 1 Credits™, 4 ACEP Category I Credits, 4 AAP Prescribed Credits, 4 AOA Category 2-A or 2-B Credits.
• Specialty CME Credits: Included as part of the 4 credits, this CME activity is eligible for 0.5 Pharmacology CME credits

Description:
Although all emergency clinicians are aware of the serious public health crises that prescription opioid overuse and misuse cause, knowing what the evidence shows about the effectiveness and safety of nonpharmacologic and pharmacologic analgesia strategies will help guide you to treatment that is safer and more effective.
• Which types of pain scales are most effective – visual, numeric, or functional?
• What are some simple, nonpharmacologic pain management strategies that you can use to augment or reduce systemic analgesia use?
• What are the most effective nonopioid drug combinations?
• Which NSAIDs are safest for use in patients with gastrointestinal, renal, and cardiac risk factors?
• When should alternative analgesics be considered: acetaminophen, ketamine, clonidine, and droperidol?
• What is the latest evidence on systemically administered lidocaine?
• When, where, and how can regional anesthesia be best used for pain control?
• What are some of the special recommendations for patients with headache, renal colic, low back pain, and neuropathic pain?
• How should you approach pain management in the patient with opioid-use disorder?

Credits
  • 4 CME
  • 4 Credits
  • 0.5 CME
  • SPECIALITIES

    Emergency MedicinePediatrics

    RELATED ONLINE COURSES

    Webcast

    Emergency Medicine
    22 AMA PRA Category 1 Credits™
    ...
    More actions
    US$199

    Webcast

    Emergency Medicine
    7.5 AMA PRA Category 1 Credits™
    ...
    More actions
    US$149

    Webcast

    Emergency Medicine
    15 AMA PRA Category 1 Credits™
    ...
    More actions
    US$109